Eric Roath, PharmD
The FDA recently approved an Investigational New Drug application submitted by Valneva SE.
A recent report in the New York Times highlights New Trials for Ecstasy as Relief for Post Traumatic Stress Disorder (PTSD) Patients. The Internet is now buzzing with chatter about how methylenedioxymethamphetamine (MDMA; also known as ecstasy) could become legal in the coming years.
On November 10, 2016, Michigan State Representatives introduced HB 6045, which would amend the Michigan Public Health Code to provide restrictions on the quantity of prescription opioid medications that can be issued by a prescriber under certain circumstances. This legislation comes on the heels of recent efforts by the CDC to raise awareness and hopefully curtail the growing opioid epidemic.
Biosimilars have been in the news quite a bit lately. Here’s an update on some of the big developments related to biosimilar development, approval, and regulations
Although Democratic presidential candidate Hillary Clinton's prescription plan was released almost a year ago, the former Secretary of State's intentions for dealing with the pharmaceutical industry were back in the news last week.
A statewide standing order enhances pharmacists' ability to provide naloxone to patients at high risk for opioid overdose.
SNOMED-CT codes are considered a core component of obtaining interoperability between electronic health records.
Several weeks back, CMS caused quite a stir when its controversial star ratings for hospitals were released to the public.
In recent years, federal agencies have introduced significant regulatory proposals impacting different facets of the pharmaceutical industry.
A great deal of learning experience obtained during residency has to do with patient care.
Health care stakeholders across the nation are working to address public health needs in creative ways, and many of their solutions involve eliminating the prescription as a barrier to accessing health care.
Entrepreneurship has a strong history in health care.
+ Load More